Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
AssigneeXenoPort, Inc.
InventorRonald W. Barrett
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of using prodrugs of GABA analogs and pharmaceutical compositions thereof to treat and/or prevent urinary incontinence in humans, and pharmaceutical compositions of prodrugs of GABA analogs useful in treating and/or preventing urinary incontinence.
Claims24
A method of treating or preventing urinary incontinence in a patient in need of such treatment or prevention comprising administering to the patient a therapeutically effective amount of a prodrug of a GABA analog, or a pharmaceutically acceptable salt, hydrate or solvate thereof.
A method of treating or preventing urinary incontinence in a patient in need of such treatment or prevention comprising administering to the patient a pharmaceutical composition comprising a therapeutically effective amount of a prodrug of a GABA analog, or a pharmaceutically acceptable salt, hydrate or solvate thereof and a pharmaceutically acceptable carrier.
A pharmaceutical composition for treating a patient suffering from urinary incontinence comprising a therapeutically effective amount of a prodrug of a GABA analog or a pharmaceutically acceptable salt, hydrate or solvate thereof and a pharmaceutically acceptable vehicle.
A pharmaceutical composition suitable for preventing urinary incontinence in a patient at risk of urinary incontinence comprising a therapeutically effective amount of a prodrug of a GABA analog or a pharmaceutically acceptable salt, hydrate or solvate thereof and a pharmaceutically acceptable vehicle.
Dependencies are inferred from the claim text.